These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28551713)

  • 61. Neural mechanisms underlying drug-related cue distraction in active cocaine users.
    Hester R; Garavan H
    Pharmacol Biochem Behav; 2009 Sep; 93(3):270-7. PubMed ID: 19135471
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selective norepinephrine reuptake inhibition by atomoxetine prevents cue-induced heroin and cocaine seeking.
    Economidou D; Dalley JW; Everitt BJ
    Biol Psychiatry; 2011 Feb; 69(3):266-74. PubMed ID: 21109233
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug Stroop: Mechanisms of response to computerized cognitive behavioral therapy for cocaine dependence in a randomized clinical trial.
    DeVito EE; Kiluk BD; Nich C; Mouratidis M; Carroll KM
    Drug Alcohol Depend; 2018 Feb; 183():162-168. PubMed ID: 29258028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Attentional bias towards cannabis cues in cannabis users: A systematic review and meta-analysis.
    O'Neill A; Bachi B; Bhattacharyya S
    Drug Alcohol Depend; 2020 Jan; 206():107719. PubMed ID: 31753732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
    Garnock-Jones KP; Keating GM
    Paediatr Drugs; 2009; 11(3):203-26. PubMed ID: 19445548
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atomoxetine improves attentional orienting in a predictive context.
    Reynaud AJ; Froesel M; Guedj C; Ben Hadj Hassen S; Cléry J; Meunier M; Ben Hamed S; Hadj-Bouziane F
    Neuropharmacology; 2019 May; 150():59-69. PubMed ID: 30876931
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Individual differences in attentional bias associated with cocaine dependence are related to varying engagement of neural processing networks.
    Kilts CD; Kennedy A; Elton AL; Tripathi SP; Young J; Cisler JM; James GA
    Neuropsychopharmacology; 2014 Apr; 39(5):1135-47. PubMed ID: 24196947
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.
    Chamberlain SR; Hampshire A; Müller U; Rubia K; Del Campo N; Craig K; Regenthal R; Suckling J; Roiser JP; Grant JE; Bullmore ET; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2009 Apr; 65(7):550-5. PubMed ID: 19026407
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fixation time is a sensitive measure of cocaine cue attentional bias.
    Marks KR; Roberts W; Stoops WW; Pike E; Fillmore MT; Rush CR
    Addiction; 2014 Sep; 109(9):1501-8. PubMed ID: 24894879
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks.
    Robinson ES
    Psychopharmacology (Berl); 2012 Jan; 219(2):303-12. PubMed ID: 21800042
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of high frequency rTMS on negative attentional bias are influenced by baseline state anxiety.
    Vanderhasselt MA; Baeken C; Hendricks M; De Raedt R
    Neuropsychologia; 2011 Jun; 49(7):1824-30. PubMed ID: 21414332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Lin HY; Gau SS
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv094. PubMed ID: 26377368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alcohol administration reduces attentional bias to alcohol-related but not food-related cues: Evidence for a satiety hypothesis.
    Monem R; Fillmore MT
    Psychol Addict Behav; 2019 Dec; 33(8):677-684. PubMed ID: 31599605
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of Cocaine-Related Images and Alcohol Administration on Inhibitory Control in Cocaine Users.
    Pike E; Marks KR; Stoops WW; Rush CR
    Alcohol Clin Exp Res; 2017 Dec; 41(12):2140-2150. PubMed ID: 28921654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Time course of attentional bias to drug cues in opioid dependence.
    Frankland L; Bradley BP; Mogg K
    Psychol Addict Behav; 2016 Aug; 30(5):601-606. PubMed ID: 27031089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task.
    Hester R; Dixon V; Garavan H
    Drug Alcohol Depend; 2006 Feb; 81(3):251-7. PubMed ID: 16095852
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Compound stimulus presentation and the norepinephrine reuptake inhibitor atomoxetine enhance long-term extinction of cocaine-seeking behavior.
    Janak PH; Bowers MS; Corbit LH
    Neuropsychopharmacology; 2012 Mar; 37(4):975-85. PubMed ID: 22089320
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
    Schulz KP; Bédard AV; Fan J; Hildebrandt TB; Stein MA; Ivanov I; Halperin JM; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):602-609.e2. PubMed ID: 28647012
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Noradrenergic regulation of cue-guided decision making and impulsivity is doubly dissociable across frontal brain regions.
    Chernoff CS; Hynes TJ; Schumacher JD; Ramaiah S; Avramidis DK; Mortazavi L; Floresco SB; Winstanley CA
    Psychopharmacology (Berl); 2024 Apr; 241(4):767-783. PubMed ID: 38001266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.